Psyence Financial Statements From 2010 to 2025
| PSYGF Stock | USD 0.13 0.00 0.00% |
Check Psyence financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence's main balance sheet or income statement drivers, such as , as well as many indicators such as . Psyence financial statements analysis is a perfect complement when working with Psyence Valuation or Volatility modules.
Psyence |
Psyence Group Company Return On Equity Analysis
Psyence's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Psyence Return On Equity | -1.66 |
Most of Psyence's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Psyence Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Psyence Group has a Return On Equity of -1.6611. This is 93.07% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—General industry. The return on equity for all United States stocks is notably higher than that of the company.
Psyence Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Psyence's current stock value. Our valuation model uses many indicators to compare Psyence value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Psyence competition to find correlations between indicators driving Psyence's intrinsic value. More Info.Psyence Group is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Psyence's earnings, one of the primary drivers of an investment's value.About Psyence Financial Statements
Psyence stakeholders use historical fundamental indicators, such as Psyence's revenue or net income, to determine how well the company is positioned to perform in the future. Although Psyence investors may analyze each financial statement separately, they are all interrelated. For example, changes in Psyence's assets and liabilities are reflected in the revenues and expenses on Psyence's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Psyence Group. Please read more on our technical analysis and fundamental analysis pages.
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada. Psyence is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Psyence Pink Sheet
Psyence financial ratios help investors to determine whether Psyence Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Psyence with respect to the benefits of owning Psyence security.